Compile Data Set for Download or QSAR
Report error Found 34 of ph data with Target = 'Arachidonate 5-lipoxygenase-activating protein'
TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125205(US8772495, 2)
Affinity DataIC50: 2.90nMpH: 7.4Assay Description:Compound 2 was examined for its ability to bind human FLAP using a membrane-binding assay. The affinity of Compound 2 for human FLAP was assessed usi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125960(US8772304, 22)
Affinity DataIC50: 3.20nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125961(US8772304, 23)
Affinity DataIC50: 4nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125940(US8772304, 2)
Affinity DataIC50: 4.20nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125941(US8772304, 3)
Affinity DataIC50: 5.90nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125939(US8772304, 1)
Affinity DataIC50: 7.10nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125964(US8772304, 26)
Affinity DataIC50: 10nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125963(US8772304, 25)
Affinity DataIC50: 12nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125942(US8772304, 4)
Affinity DataIC50: 13nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125966(US8772304, 28)
Affinity DataIC50: 17nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125958(US8772304, 20)
Affinity DataIC50: 19nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125959(US8772304, 21)
Affinity DataIC50: 20nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125965(US8772304, 27)
Affinity DataIC50: 23nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125962(US8772304, 24)
Affinity DataIC50: 23nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125943(US8772304, 5)
Affinity DataIC50: 29nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125971(US8772304, 33)
Affinity DataIC50: 34nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125949(US8772304, 11)
Affinity DataIC50: 46nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125951(US8772304, 13)
Affinity DataIC50: 51nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125955(US8772304, 17)
Affinity DataIC50: 58nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125944(US8772304, 6)
Affinity DataIC50: 86nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125947(US8772304, 9)
Affinity DataIC50: 110nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125948(US8772304, 10)
Affinity DataIC50: 138nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125968(US8772304, 30)
Affinity DataIC50: 180nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125970(US8772304, 32)
Affinity DataIC50: 220nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125957(US8772304, 19)
Affinity DataIC50: 270nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125952(US8772304, 14)
Affinity DataIC50: 279nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125967(US8772304, 29)
Affinity DataIC50: 300nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125956(US8772304, 18)
Affinity DataIC50: 450nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125945(US8772304, 7)
Affinity DataIC50: 540nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125969(US8772304, 31)
Affinity DataIC50: 542nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125946(US8772304, 8)
Affinity DataIC50: 620nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125950(US8772304, 12)
Affinity DataIC50: 700nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125953(US8772304, 15)
Affinity DataIC50: 870nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent

TargetArachidonate 5-lipoxygenase-activating protein(Human)
Panmira Pharmaceuticals

US Patent
LigandPNGBDBM125954(US8772304, 16)
Affinity DataIC50: 960nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
Go to US Patent